Thanks to its experimental gene therapy injection for COVID-19, in 2022, Pfizer became the first drug company in history to break $ 100 billion in annual sales.1 But its mere existence didn’t ensure Pfizer’s success. No, massive media promotion and government-backed coercion did that. Not only did the U.S. government pay news media a staggering… Read More »
According to Kaiser Health News (KHN),1 the COVID-19 pandemic has been a real boon to Pfizer. Not only has it yielded “outsize benefits” in terms of profits, but it has also “given the drugmaker unusual weight in determining U.S. health policy.” “Based on internal research, the company’s executives have frequently announced the next stage in… Read More »
Despite the FDA’s claim that it is committed to transparency, especially for COVID-19 emergency use authorizations (EUAs),1 the agency first requested 55 years to release the data supporting the approval of Comirnaty after a Freedom of Information Act (FOIA) request was filed,2 and then asked for an extra 20 years to fully comply.3 Pfizer has… Read More »
Breadcrumb Trail Links News Health Canada While health authorities are reassuring Canadians that it’s safe to mix COVID-19 vaccines doses, some appear to be rejecting Moderna for Pfizer Author of the article: Sharon Kirkey Publishing date: Jun 24, 2021 • 4 days ago • 5 minute read • 126 Comments “There may be some brand recognition… Read More »